How to Treat Fatty Liver/NASH in a Clinical Trial
The Newest Ways to Treat Fatty Liver/NASH
If you have been diagnosed with Fatty Liver/NASH and want the latest, most cutting-edge treatments available, you may be perfect for a Fatty Liver/NASH Clinical Trial. Clinical trials are a great way to advance medical science, earn extra cash, and potentially treat or improve your condition. Have you always wondered what being part of a clinical trial would be like? Keep reading to learn more about the Fatty Liver/NASH Clinical Trial and how to pre-qualify today as a participant.
Have You Been Diagnosed with Fatty Liver/NASH?
Nonalcoholic fatty liver disease (NAFLD) is a condition in which fat builds up in your liver. Nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH) are types of NAFLD. If you have NASH, you have inflammation and liver damage, along with fat in your liver.
If you have been diagnosed with NASH, you may be eligible for a clinical trial being conducted by Metabolic Disease Clinical Trials. In this trial, we are allowing participants exclusive access to cutting-edge treatments.
What You Should Know About the Fatty Liver/NASH Clinical Trial
Want to become part of this clinical trial and potentially improve your NASH condition? Here is important information you should know:
- Enrolling is quick and easy. Simply click here to provide us with your contact information. We will pre-qualify you over the phone, meet with you in person to finalize your eligibility, and then ask you to join if you qualify. It is simple!
- Everything is paid for by the study. Absolutely no medical insurance, proof of citizenship, or payment will be asked or required of you. All medical consultations, exams, and study-related medication is paid for completely by the study.
- You will be compensated. All participants will be compensated for their time and travel as participants in the study.
Participant Information
As a participant in the study, we offer you the following guarantees:
- Free consultation and health examination
- Free lab reports
- Free study-related medicines
- Safety guidelines strictly followed
- Governed & monitored by the central ethics committee
- Compensation for your time and travel
- FDA-governed
- HIPAA-compliant
The Fatty Liver/NASH study is part of the Alliance Clinical Network, a group of clinical research sites that conduct Phase II-IV clinical trials.
- Phase II studies test treatments that have been found to be safe in Phase I but now need a larger group of human subjects to monitor for any adverse effects.
- Phase III studies are conducted on larger populations and in different regions and countries and are often the step right before a new treatment is approved.
- Phase IV studies take place after country approval, and there is a need for further testing in a wide population over a longer timeframe.
For more information or to sign up as a participant today, visit us at MetabolicDiseaseClinicalTrials.com!
